跳至主要内容
临床试验/DRKS00027459
DRKS00027459已完成未知

Evaluation of the effectiveness of an online-based support program for the treatment of depression (Novego®) - A randomized controlled trial

IVP Networks GmbH0 个研究点目标入组 311 人开始时间: 2021年12月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
311

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • one of the following diagnoses according to ICD-10 made by specialists or psychotherapists: F32.0, F32.1, F32.2, F32.8, F32.9, F33.0, F33.1, F33.2, F33.8, F33.9, F34.1
  • A sum score on the PHQ-9 at the time of the baseline interview of at least 5 (at least mild expression of depression)
  • informed consent
  • access to the Internet
  • sufficient knowledge of the German language
  • willingness to participate in three anonymous online surveys and willingness to independently use Novego - Depressionen bewältigen®.
  • Patients must be in a stable therapy situation (pharmacotherapy and/or psychotherapy or waiting situation) at least 4 weeks before randomization and should maintain this situation as far as possible during the study period.

排除标准

  • the presence of a psychotic or bipolar disorder (lifetime)
  • acute suicidal behavior within the last 4 weeks
  • alcohol or substance dependence within the last 6 months
  • current use of antipsychotics
  • Presence of a serious illness which, in the opinion of the investigator, precludes the patient's participation in the study until the end of the study

研究者

发起方
IVP Networks GmbH

相似试验